{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:24:34Z","timestamp":1773289474539,"version":"3.50.1"},"reference-count":9,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"unspecified","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2025,3,12]]},"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A person\u2019s beliefs about treatment influence their engagement and adherence to that treatment. The Necessity-Concerns Framework suggests that adherence is influenced by a person\u2019s judgement of their own need for treatment (necessity beliefs) and concerns about the potential adverse consequences of taking the treatment. This study was conducted to explore the Necessity-Concerns Framework for elexacaftor-tezacaftor-ivacaftor (ETI) therapy (Kaftrio) in adults with cystic fibrosis (CF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 64 adults with CF were maintained on ETI therapy as part of their routine CF care, and completed the Beliefs about Medicines Questionnaire. Patient demographics, lung function, body mass index and quality of life using the Cystic Fibrosis Questionnaire Revised were collected as part of routine clinical care. Duration of ETI therapy along with medicines possession ratio was recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients reported strong beliefs about the necessity of ETI therapy. The majority of patients (78%) reported low concerns about ETI therapy while 22% of patients reported high concerns. A small number of patients (n=4) had concerns which were stronger than their beliefs about necessity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Patients reported strong beliefs in the necessity of ETI therapy. Although concerns were lower, a significant proportion of the sample had strong concerns about their ETI therapy. By being aware of people with CF\u2019s necessity and concerns beliefs around ETI therapy clinical teams will be better armed to engage them in treatment decisions and support optimal adherence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2024-002546","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T02:33:39Z","timestamp":1743474819000},"page":"e002546","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Understanding beliefs about elexacaftor-tezacaftor-ivacaftor therapy in adults living with cystic fibrosis"],"prefix":"10.1136","volume":"12","author":[{"given":"Catherine","family":"O\u2019Leary","sequence":"first","affiliation":[{"name":"Respiratory Medicine, Cardiff and Vale University Health Board, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alec","family":"Vinh","sequence":"additional","affiliation":[{"name":"Cardiff University, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1731-1203","authenticated-orcid":false,"given":"Mari","family":"Lea-Davies","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, Cardiff and Vale University Health Board, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Weinman","sequence":"additional","affiliation":[{"name":"King\u2019s College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Horne","sequence":"additional","affiliation":[{"name":"University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3004-279X","authenticated-orcid":false,"given":"Jamie","family":"Duckers","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, Cardiff and Vale University Health Board, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"2026010701501741000_12.1.e002546.1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/21556660.2021.1912352","article-title":"Adherence to cystic fibrosis transmembrane conductance regulator (CFTR) modulators: analysis of a national specialty pharmacy database","volume":"10","author":"Mehta","year":"2021","journal-title":"J Drug Assess"},{"key":"2026010701501741000_12.1.e002546.2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jcf.2015.05.009","article-title":"Electronic monitoring reveals highly variable adherence patterns in patients prescribed ivacaftor","volume":"14","author":"Siracusa","year":"2015","journal-title":"J Cyst Fibros"},{"key":"2026010701501741000_12.1.e002546.3","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-215556"},{"key":"2026010701501741000_12.1.e002546.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(99)00057-4"},{"key":"2026010701501741000_12.1.e002546.5","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/jsn135"},{"key":"2026010701501741000_12.1.e002546.6","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-015-0038-7","article-title":"Adherence to treatment in children and adolescents with cystic fibrosis: a cross-sectional, multi-method study investigating the influence of beliefs about treatment and parental depressive symptoms","volume":"15","author":"Goodfellow","year":"2015","journal-title":"BMC Pulm Med"},{"key":"2026010701501741000_12.1.e002546.7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08870449908407311","article-title":"The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication","volume":"14","author":"Horne","year":"1999","journal-title":"Psychology & Health"},{"key":"2026010701501741000_12.1.e002546.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080633","article-title":"Understanding Patients\u2019 Adherence-Related Beliefs about Medicines Prescribed for Long-Term Conditions: A Meta-Analytic Review of the Necessity-Concerns Framework","volume":"8","author":"Horne","year":"2013","journal-title":"PLoS ONE"},{"key":"2026010701501741000_12.1.e002546.9","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/rheumatology\/kem060","article-title":"The Common-Sense Model of self-regulation of health and illness: how can we use it to understand and respond to our patients\u2019 needs?","volume":"46","author":"Hale","year":"2007","journal-title":"Rheumatology (Sunnyvale)"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2024-002546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:50:33Z","timestamp":1767779433000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2024-002546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":9,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3,31]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1136\/bmjresp-2024-002546"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2024-002546","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}